Views & Analysis How will STPs change the face of the NHS in 2017? What changes will STPs bring and what are the implications for pharma?
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
